Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2020-04-13 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
关于召开2019年年度股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2019 Annual General Meeting (AGM) of 金宇生物技术股份有限公司. It includes information about the date, voting methods, agenda items to be discussed and voted on, registration procedures, and proxy authorization forms. The document does not contain the actual annual report or financial statements but rather serves as a notice and instructions for shareholders about the upcoming AGM. The document length is 3857 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM itself.
2020-04-13 Chinese
2019年年度股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as "2019 年年度股东大会会议资料" which translates to "2019 Annual General Meeting (AGM) materials". It contains detailed agenda items for the AGM, including reports from the board of directors, supervisory board, financial reports, profit distribution proposals, and independent directors' reports. The content is consistent with materials typically shared during an AGM to inform shareholders and facilitate voting. The document is lengthy (15,000 characters) and includes multiple reports and proposals to be discussed at the AGM, which aligns with the definition of AGM Information (AGM-R). It is not a standalone annual report (10-K) or a voting results announcement (DVA), but rather the presentation and materials for the AGM itself.
2020-04-13 Chinese
关于全资子公司获得中国合格评定国家认可委员会（CNAS）认可决定书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about its wholly-owned subsidiary receiving an accreditation decision from the China National Accreditation Service (CNAS). It details the scope of the accreditation and its implications for the subsidiary's laboratory activities. The document is short (1119 characters) and does not contain financial data, financial results, or detailed reports. It is an official announcement regarding a regulatory or certification update rather than a financial report or management information. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a regulatory filing in the sense of compliance or officer certification. The best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2020-04-08 Chinese
关于以集中竞价交易方式回购股份的进展公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the progress of a share repurchase program by the company 金宇生物技术股份有限公司. It details the number of shares repurchased, the price range, total amount paid, and compliance with relevant regulations. The document does not contain full financial statements or detailed financial analysis but is focused on the update of the company's share buyback activity. According to the filing definitions, this fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. The document length is short and it is not a report publication announcement or a regulatory filing. Therefore, the appropriate classification is POS with high confidence.
2020-04-02 Chinese
关于股东股份解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement regarding the release of pledged shares by a major shareholder of the company. It details the number of shares released from pledge, the remaining pledged shares, and the shareholding percentages before and after the release. There is no financial performance data, no discussion of earnings, no management commentary, and no mention of report attachments or filings. The content focuses solely on share pledge status updates, which is a capital structure related disclosure. This fits the category of Capital/Financing Update (CAP). The document length is short and it is not an announcement of a report publication, so it is not RPA. It is not a regulatory filing or certification. Therefore, the best classification is CAP with high confidence.
2020-04-01 Chinese
2019年年度报告
Annual Report Classification · 100% confidence The document is titled '2019 年年度报告' which translates to '2019 Annual Report'. It contains detailed sections typical of an annual report such as company overview, financial data, management discussion and analysis, corporate governance, and audited financial statements. The document includes comprehensive financial figures, business overview, risk disclosures, and management commentary. It also mentions an unqualified audit opinion from the accounting firm, which is typical for an annual report. The length of the document (15,000 characters) and the detailed content confirm it is the full annual report, not just an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2019
2020-03-29 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.